These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 7924823)
1. New developments in non-specific and semi-specific immunosuppression in type I diabetes. Leslie RD; Carotenuto P; Pozzilli P Diabetes Metab Rev; 1993 Dec; 9(4):257-67. PubMed ID: 7924823 [No Abstract] [Full Text] [Related]
2. [Immunointervention in newly diagnosed type 1 diabetes]. Kaupper T; Walter M; Ziegler AG Dtsch Med Wochenschr; 2006 Dec; 131(49):2783-8. PubMed ID: 17136660 [No Abstract] [Full Text] [Related]
3. Immunointervention in type 1 (insulin-dependent) diabetes mellitus. Keymeulen B; Somers G Acta Clin Belg; 1993; 48(2):86-95. PubMed ID: 8392249 [TBL] [Abstract][Full Text] [Related]
5. Prediction, prevention, and early intervention in insulin-dependent diabetes. Andreani D; Di Mario U; Pozzilli P Diabetes Metab Rev; 1991 Mar; 7(1):61-77. PubMed ID: 1935536 [No Abstract] [Full Text] [Related]
6. Clinical review 17: Immunotherapy of type I diabetes mellitus. Marks JB; Skyler JS J Clin Endocrinol Metab; 1991 Jan; 72(1):3-9. PubMed ID: 1986025 [No Abstract] [Full Text] [Related]
8. Trials of immunotherapy to preserve beta-cell function of prediabetic and new-onset patient trials. Eisenbarth GS Curr Diab Rep; 2004 Apr; 4(2):85-6. PubMed ID: 15035966 [No Abstract] [Full Text] [Related]
9. Diagnosis and treatment of pre-insulin dependent diabetes. Gottlieb PA; Eisenbarth GS Annu Rev Med; 1998; 49():391-405. PubMed ID: 9509271 [TBL] [Abstract][Full Text] [Related]
10. [Screening of pre-diabetes type I: Why? How? Whom?]. Assan R; Larger E Journ Annu Diabetol Hotel Dieu; 1992; ():123-30. PubMed ID: 1495231 [No Abstract] [Full Text] [Related]
11. [Screening of pre-diabetes type I: possibilities and limits]. Timsit J; Caillat-Zucman S; Boitard C; Bach JF Journ Annu Diabetol Hotel Dieu; 1992; ():131-8. PubMed ID: 1495232 [No Abstract] [Full Text] [Related]
12. Towards secondary prevention of Type 1 diabetes. David Leslie R Diabet Med; 2011 Oct; 28(10):1140. PubMed ID: 21848636 [No Abstract] [Full Text] [Related]
13. In vivo function of pig islet xenografts in immunosuppressed diabetic mice. Tai J; Cheung SS; Tsang A; Tze WJ Transplant Proc; 1995 Dec; 27(6):3316-7. PubMed ID: 8539968 [No Abstract] [Full Text] [Related]
17. Induction of functional xenograft tolerance of pig islets in the autoimmune NOD mouse. Thomas FT; Pittman K; Thomas JM Transplant Proc; 1995 Dec; 27(6):3323-5. PubMed ID: 8539973 [No Abstract] [Full Text] [Related]
18. Intranasal administration of insulin peptide B: 9-23 protects NOD mice from diabetes. Daniel D; Wegmann DR Ann N Y Acad Sci; 1996 Feb; 778():371-2. PubMed ID: 8610993 [No Abstract] [Full Text] [Related]
19. Epidemiological and ethical consiluations on trials with immunotherapy in pre-type 1 (insulin-dependent) diabetes mellitus. Dahlqvist G Diabetologia; 1991 Jul; 34(7):536. PubMed ID: 1916062 [No Abstract] [Full Text] [Related]
20. Approaches to prevention and treatment of IDDM in animal models. Gottlieb PA; Rossini AA; Mordes JP Diabetes Care; 1988; 11 Suppl 1():29-36. PubMed ID: 3069388 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]